LAUREL BEELER, Magistrate Judge.
In this putative class action, Plaintiffs Djeneba Sidibe and Diane Dewey sued Sutter Health, a company that owns and operates hospitals and other health care service providers, alleging that Sutter's anticompetitive conduct in the health care services industry in Northern California violates federal and state antitrust laws and California's unfair competition law. See generally First Amended Complaint ("FAC"), ECF No. 15.
Sutter moved to dismiss for lack of standing and for failure to state a claim. See Motion, ECF No. 15. The court grants Sutter's motion to dismiss without prejudice and with leave to amend.
Defendant Sutter Health is a non-profit corporation organized and existing under California laws, with its principal place of business in Sacramento, California. FAC, ECF No. 11, ¶ 19. Sutter provides health care and related services
The FAC makes allegations about Sutter's non-profit status, see id. ¶¶ 109-123, but also states that "[t]his action does not concern Sutter Health's non-profit status." Id. ¶ 113. Plaintiffs allege that Sutter "styles itself as a `non-profit'" to avoid taxes, but it really is one of the most profitable health care operations in the country. Id. ¶ 109. Sutter generates over $9 billion in annual revenue and as of September 30, 2011, it had accumulated $4.4 billion in cash and investments. Id. ¶ 109. Sutter's true profits may be higher than this. Id. ¶ 111. Sutter also has a "de facto network" beyond its "publicly disclosed network" that includes numerous for-profit entities. Id. ¶ 110. Sutter provides its managers and directors with "massive salary and benefit packages." Id. ¶ 109. Many of the same individuals have occupied key positions of control at Sutter for the last two decades and that their conduct is "unaccountable and non-transparent." Id. ¶¶ 119-23.
Since around October 2005, Plaintiff Djeneba Sidibe is and has been enrolled in a licensed health care plan that has a contractual relationship with Sutter for health care services. Id. Sidibe lived in San Mateo County before November 2009, Alameda County from November 2009 to January 2012, and Marin County since January 2012. Id. Plaintiff Diane Dewey has lived in San Francisco County since 1994. Id. ¶ 18. At various times during the relevant period, including the present, Dewey has been enrolled in a licensed health care plan that has a contractual relationship with Sutter for health care services. Id.
Sidibe and Dewey claim that they and other members of the class have been injured as a result of Sutter's allegedly anti-competitive conduct by paying more for health care services than they otherwise would have paid. Id. ¶¶ 17-18. Plaintiffs allege that Sutter's conduct "deprive[s] every resident of Northern California of at least several thousand dollars per year." Id. ¶ 101. These higher costs are the result of (1) Sutter's "contracts with health plans that impose tying," (2) Sutter's "contracts with health plans that force those plans to impose exclusivity on their enrollees," and (3) Sutter's "contracts with physician groups that force the doctors to refer to Sutter service providers." Id. ¶¶ 98-100.
Plaintiffs seek to represent a class, defined as:
Id. ¶ 130.
Health care providers such as Sutter typically charge retail prices that are three to ten times higher than their contract prices. Id. ¶ 3. As a result, if a health plan does not have contracted access to a hospital or provider, the health plan cannot afford to include the provider in the provider network it makes available to members. Id. If the health plan cannot contract with a provider, the provider must remain "outside-of-plan." Id. In order to comply with the requirements of California's Knox-Keene Health Care Service Plan Act of 1975 (the "Knox-Keene Act"),
Sutter engages in anti-competitive agreements or combinations with health plans that eliminate competition in the market for health care services. Id. ¶ 4. Specifically, Sutter
Id. ¶ 4. By engaging in this conduct, Sutter has intentionally destroyed competition for health care services in Northern California in order to impose prices on the ten million Northern California residents that are 40% to 80% greater than they could obtain in a competitive market. Id. ¶ 5. Sutter executed an expansion strategy designed to increase its geographic concentration, local market dominance, and functional reach by acquiring hospitals, physicians' groups, and providers of ancillary medical services, such as laboratories, radiation services, in-home care, and skilled nursing facilities. Id. ¶ 6.
Sutter's expansion strategy and its other anti-competitive practices — including coercive market domination, tying, and unreasonable exclusionary agreements — have stifled competition for health care services in Northern California. Id. ¶ 9. For example, purchasers of health care services on behalf of consumers cannot select among the providers in a given region based on quality and price. Id. ¶ 9. If a health plan were to insist on selecting providers based on quality and price, they would be denied contracted access to any part of Sutter's network, which would effectively mean that the health plan could not do business in Northern California at all. Id. ¶ 9.
The health care market is unique because purchases can be a matter of life or death. Id. ¶ 34. Close substitutes do not exist and the barriers to entry are high. Id. Sutter primarily operates in a relevant geographic market defined as "the provision of health care and related services in the following counties: Alameda, Contra Costa, San Francisco, Marin, Sonoma, Napa, San Mateo, Santa Clara, Santa Cruz, Solano, Yolo, Sutter, Yuba, Nevada, Sacramento, Amador, Placer, El Dorado, San Joaquin, Stanislaus, Merced and Lake." Id. ¶ 35.
There also is "a relevant market for the provision of contracted access to health care services in Northern California through health plans. Id. ¶ 37 (emphasis omitted). This market excludes all parts of the Kaiser network because Kaiser Permanente is a closed system and its services are not available on a contracted basis to health plans. Id. ¶ 37 n.3. Health plans in the relevant market "must comply with relevant laws and regulations, including the Knox-Keene Act and the regulations promulgated thereunder." Id. ¶ 37.
The Knox-Keene Act and its regulations define the minimum scope of services and accessibility standards for health plans to operate in California. The Plan License Application under the Knox-Keene Act states:
Id. ¶ 38.
Sutter's size and dominant position in the Northern California health care market allow it to exercise market power through its contracts and combinations with health plans in the relevant market. Id. ¶ 40. Sutter does this
Id. ¶ 39.
Sutter is dominant in the Northern California health care market. Id. ¶ 40. Excluding closed systems such as Kaiser Permanente, Sutter has amassed the following: 100% of the hospital beds in Placer and Amador counties; 60% of the beds in Alameda and Contra Costa counties; and over 50% of the beds in San Francisco and Sacramento. Id. ¶ 41. Sutter has 35% of the revenue and 36% of the hospital beds that compete for patients in Northern California. Id.
Different sources corroborate that Sutter charges more than other hospitals and that this has increased health care costs throughout Northern California. See generally id. ¶¶ 42-49. These sources include the Federal Trade Commission, ¶ 42, the California Public Employees' Retirement System ("CalPERS") and its officers, ¶¶ 43-44, Blue Cross of California, ¶ 44, Bloomberg, ¶ 45, the Los Angeles Times, ¶ 46, the California Public Interest Research Group ("CALPIRG"), ¶¶ 47-49 & figs. 1-2. The portions of California "exhibiting abnormally high hospital prices and the region comprising Sutter Health's territory precisely correspond." Id. ¶ 48.
The "`systemwide contracts' negotiated by Sutter Health on an `all or none' basis . . . artificially inflate every dollar of revenue that Sutter Health collects." Id. ¶ 50. Sutter's strategy is as follows:
Id. ¶ 50.
A "second prong" of Sutter Health's strategy is to
Id. ¶¶ 53-54. For example, the Palo Alto Medical Foundation has contracts with medical groups that include approximately 1,098 physicians. Id. ¶ 55. They directed visits, procedures, tests, and surgeries away from non-Sutter hospitals, physicians, and laboratories, even when those competitors offered lower prices or superior quality. Id. ¶ 56.
In addition, "a commercial reality" related to Sutter's market power is that its "more potentially formidable competitors, such as Kaiser Permanente, simply shadow price Sutter Health." Id. ¶ 58. According to excerpts from a December 2012 presentation by "HSS, the largest employer in San Francisco," "Sutter charges the highest fees," other providers in the "Bay area market . . . shadow Sutter's prices," and the lack of competition causes increased premiums. Id. ¶¶ 58-59.
Sutter includes the following tying language in its agreements with health plans:
Id. ¶ 60. This "all or none language . . . in its contracts with health plans is the mechanism through which Sutter Health effectuates its anti-competitive tying conduct." Id. ¶ 61. The intended objective of such language is to prevent health plans from using Sutter facilities only in regions or for services the health plan needs. Id. ¶ 62. Absent such language, where Sutter has less market power, the health plans could use non-Sutter facilities. Id. Thus, "[t]he effect of such tying is to impose supra-competitive prices and lower quality on the plaintiffs and members of the class." Id.
The accessibility standards discussed previously effectively force the health plans to agree to these tying contracts. Id. ¶ 63. Under California regulations governing the scope of services that a California health plan must provide, "health plans are obligated to assemble a comprehensive network of a broad spectrum of medical services providers that must be available within a 15-minute radius of every enrollee." Id. ¶¶ 63-64 (quoting Cal. Code Regs. tit. 28, § 1300.67 (2012)). Market pressures also encourage health plans to have as large a coverage area as possible. Id. ¶ 64.
The health plans' need to provide as large a coverage area as possible and the accessibility regulations mean that "anyone who is the only provider in a 15-mile radius of one of the required services has a pure monopoly." Id. ¶ 65. Sutter "possesses many hundreds of such monopolies" that allow it to exercise an "under the radar" market power. Id. ¶ 65.
For example, Sutter owns all but one non-Kaiser hospital in Alameda, and the non-Sutter hospital is 17 miles from the center of Oakland. Id. ¶ 66. The result is that any health plan without access to Sutter's hospitals must require its members to travel to a hospital outside the 15-mile/30-minute regulatory limit. Id. ¶ 66. Thus, the health plans "arguably have a legal obligation under California laws and regulations to gain contracted access to Sutter Health hospitals in Alameda County." Id. ¶ 67.
The FAC provides additional examples to show that Sutter "forces health plans to choose between `all' and `none,' and `none' would be a disaster." Id. ¶ 68. These include the failure of "the City of San Francisco's experiment beginning July 2011 to create to competing Accountable Care Organizations ("ACO") for city employees." Id. ¶ 68. Plaintiffs assert that this experiment at increasing competition failed because Sutter "limited the availability of contracted rates for emergency room services at Sutter Health hospitals to Sutter Health members," which forced the non-Sutter ACO to pull out of the experiment and sign a contract with Sutter. Id. ¶¶ 68-70. Thus, Sutter "used its market power to scuttle the City of San Francisco's attempt to create real competition." Id. ¶ 71. Sutter's tying agreements also affect the market for acute inpatient services in Amador and Placer Counties, and Sutter has substantial market power for various services in "large swatches of the East Bay, . . . Tracy, San Francisco County, and Solano County." Id. ¶ 73.
Sutter also engages in tying across regions. Id. ¶¶ 74-75. Thus, a health plan that needs access to, for example, Sutter's Alameda County hospitals, must contract with all of Sutter's hospitals across Northern California, and all of Sutter's "affiliated physician groups, laboratories, skilled nursing facilities, home care facilities, device suppliers, and so on." Id. ¶ 74. Furthermore, all of these entities "must in turn refer any patient who needs acute care to Sutter Health hospitals, any patient who needs blood work to Sutter Health labs . . . and so on." Id. ¶ 74. The effect of this is to deprive competing hospitals of customers (even in otherwise competitive areas). Id. ¶ 75.
Sutter's own strategic planning document states that its "tying services and regions are `indispensable' to health plans attempting to comply with the minimum scope of services and accessibility standards for California health plans." Id. ¶ 76. Another effect of these practices is that Sutter's network "does not compete on quality any more than it competes on price." Id. ¶ 77 (quoting a California Health Care Coalition report about Sutter).
Sutter's anti-competitive tactices have been successful only because of:
Id. ¶ 78.
Several Sutter strategic planning documents became public during a 1999 trial in which the California Attorney General sought to enjoin Sutter's purchase of Summit hospital. See id. ¶¶ 86-88. Plaintiffs assert that these documents show Sutter's plan for "market share growth" to obtain a "critical presence" in certain geographic markets and how it uses its market share to stifle competition, increase prices, and "eliminate the health plans' option to buy services at the margin." Id. ¶¶ 86-88. Hospitals (including Eden Medical Center and Summit Medical Center) that were subsequently acquired by Sutter substantially increased their prices. Id. ¶¶ 89-91.
Sutter "also typically includes language such as the following" in its agreements with health plans:
Id. ¶ 92 (emphasis in original). This "exclusivity language" and the "mandatory referral provisions reinforce and spread the anti-competitive effects" of Sutter's monopolies and tying. Id. ¶¶ 93-97.
Sutter's conduct of "tying and exclusive dealing has resulted in illegal restraints on trade and dramatically increased price[s] paid by consumers for contracted access to health care in Northern California." Id. ¶ 124. Multiple sources corroborate that Sutter's prices are higher, and its own documents demonstrate the lack of justification or pro-competitive effects of its conduct. Id. ¶¶ 124-29.
Plaintiffs filed an original complaint and then the FAC, which Sutter moved to dismiss. See ECF Nos. 1, 11, 15. The FAC alleges the following claims: (1) unreasonable restraint of trade in violation of the Sherman Act Section 1, 15 U.S.C. § 1; (2) monopolization in violation of Sherman Act Section 2, 15 U.S.C. § 2; (3) unreasonable restraint of trade in violation of the Cartwright Act, Cal. Bus. & Prof. Code Section 16720, et. seq.; (4) unfair competition, in violation of California's Unfair Competition Law ("UCL"), Cal. Bus. & Prof. Code Section 17200, et. seq.; and (5) unjust enrichment. FAC, ECF No. 11 at ¶¶ 139-188. Plaintiffs seek the following relief: (1) injunctive relief under the Sherman Act; (2) treble monetary damages, injunctive and declaratory relief, and attorney's fees and costs under the Cartwright Act; (3) "equitable relief including restitution and/or disgorgement of all revenues, earnings, profits, compensation, and benefits that may have been obtained by Sutter Health as a result of" the UCL violation; and (4) "disgorgement of all profits resulting from [the alleged] overpayments and establishment of a constructive trust from which plaintiffs and members of the Class may seek restitution." Id. ¶¶ 149, 159, 168, 181, 187.
This court has subject matter jurisdiction over the Sherman Act claims under 28 U.S.C. §§ 1331 and 1337 and supplementary jurisdiction over the state law claims under 28 U.S.C. § 1367. See id. ¶¶ 13-14. The court has subject matter jurisdiction over the claims under the Class Action Fairness Act, ("CAFA"), 28 U.S.C. § 1332(d) because the amount in controversy exceeds $5 million. Id. ¶ 15.
Rule 8(a) requires that a complaint contain a "short and plain statement of the claim showing that the pleader is entitled to relief." Fed. R. Civ. P. 8(a)(2). A complaint therefore must provide a defendant with "fair notice" of the claims against it and the grounds for relief. See Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 555 (2007).
A court may dismiss a complaint under Federal Rule of Civil Procedure 12(b)(6) when it does not contain enough facts to state a claim to relief that is plausible on its face. See id. at 570. "A claim has facial plausibility when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged." Ashcroft v. Iqbal, 129 S.Ct. 1937, 1949 (2009). "The plausibility standard is not akin to a `probability requirement,' but it asks for more than a sheer possibility that a defendant has acted unlawfully." Id. (quoting Twombly, 550 U.S. at 557). "While a complaint attacked by a Rule 12(b)(6) motion to dismiss does not need detailed factual allegations, a plaintiff's obligation to provide the `grounds' of his `entitle[ment] to relief' requires more than labels and conclusions, and a formulaic recitation of the elements of a cause of action will not do. Factual allegations must be enough to raise a right to relief above the speculative level." Twombly, 550 U.S. at 555 (internal citations and parentheticals omitted). As to Sherman Act claims, "proceeding to antitrust discovery can be expensive." Id. at 558 (addressing pleading standard in Sherman Act Section 1 claims). Thus, the court must "insist upon some specificity in pleading before allowing a potentially massive factual controversy to proceed." Id. The decision explained,
Id.
In considering a motion to dismiss, a court must accept all of the plaintiff's allegations as true and construe them in the light most favorable to the plaintiff. See id. at 550; Erickson v. Pardus, 551 U.S. 89, 93-94 (2007); Vasquez v. Los Angeles County, 487 F.3d 1246, 1249 (9th Cir. 2007). In addition, courts may consider documents attached to the complaint. Parks School of Business, Inc. v. Symington, 51 F.3d 1480, 1484 (9th Cir. 1995). If the court dismisses the complaint, it should grant leave to amend even if no request to amend is made "unless it determines that the pleading could not possibly be cured by the allegation of other facts." Lopez v. Smith, 203 F.3d 1122, 1127 (9th Cir. 2000) (quotation omitted).
Section 1 prohibits (1) a contract between two or more unrelated persons or distinct businesses entities (2) that the persons or entities intend to harm or unreasonably restrain competition and (3) that actually injures competition. See Twombly, 550 U.S. at 548; Kendell v. Visa U.S.A., Inc., 518 F.3d 1042, 1047 (9th Cir. 2008). Second 2 prohibits monopolies. A section 2 claim has two elements: "(1) the possession of monopoly power in the relevant market; and (2) the willful acquisition or maintenance of that power as distinguished from growth or development as a consequence of a superior product, business acumen, or historic accident." United States v. Grinnell Corp., 384 U.S. 563, 570-571 (1966).
Plaintiffs charge that Sutter's contracts with health plans are unlawful tying or exclusive dealing arrangements that violate section 1 by injuring competition and section 2 by enabling Sutter to maintain and enhance its monopoly power for health-care services. See FAC ¶¶ 143, 152-55.
An exclusive dealing arrangement is when a seller agrees with a buyer to sell its products or services only to that buyer, or the buyer agrees to buy only from the seller. See Allied Orthopedic Appliances v. Tyco Health Care Grp. LP, 592 F.3d 991, 996 (9th Cir. 2010). To violate section 1 as an unlawful exclusive-dealing arrangement, a threshold requirement is that the contract foreclose a substantial percentage of the market as a whole from competition. See id.
Tying involves an agreement by the seller to sell a product (the "tying" product) only if the buyer also will buy a different product (the "tied" product) (or at least agree not to buy it from anyone other than the seller). See Northern Pac. Ry. Co. v. United States, 356 U.S. 1, 5-6 (1958). An unlawful tying arrangement requires an anticompetitive effect. See Cascade Health Solutions v. PeaceHealth, 515 F.3d 883, 913 (9th Cir. 2008) (seller must possess appreciable economic power in the tying product market to coerce purchase of the tied product, and the tying arrangement must affect more than an insubstantial volume of commerce in the tied product market).
In addition to establishing the elements of the Sherman Act claims, plaintiffs must plead "that they were harmed by the defendant's anticompetitive contract . . . and that this harm `flowed from an anti-competitive aspect of the practices under scrutiny.'" Brantley v. NBC Universal, Inc., 675 F.3d 1192, 1197 (9th Cir. 2012) (quoting Atlantic Ritchfield Co. v. USA Petroleum Co., 495 U.S. 328, 344 (1990)); accord Allied Orthopedic, 592 F.3d at 998. "This fourth element is generally referred to as `antitrust injury' or `antitrust standing'" (as is explained in more detail in the next section). See Brantley, 675 F.3d at 1197 (citing as an example Atlantic Ritchfield Co., 495 U.S. at 344).
Sutter challenges Plaintiffs' antitrust standing
Sutter argues that Plaintiffs do not have antitrust standing under the Sherman Act because (a) they did not allege sufficiently that they were customers of Sutter, and (b) they are not parties to the contracts and instead are only indirect purchasers of Sutter's services. See Motion, ECF No. 15 at 13-18.
Associated General Contractors set forth factors that a court should consider when evaluating antitrust standing:
See Associated Gen. Contractors, Inc. v. California State Council of Carpenters, 459 U.S. 519, 535-46 (1983); American Ad Mgmt., Inc. v. General Telephone Co. of Cal., 190 F.3d 1051, 1054-55 (9th Cir. 1999) (listing the factors somewhat differently by joining closeness and causal connection with directness and characterizing the nature of the alleged injury as whether it was the type of injury antitrust laws were designed to forestall). The only factor that a plaintiff must show is antitrust injury. See Associated Gen. Contractors, 459 U.S. at 535. Otherwise, the other factors are not absolute requirements and instead are balanced by the court to determine antitrust standing. Id.; see Amarel v. Connell, 102 F.3d 1494, 1507 (9th Cir. 1997). "No single factor is decisive." R.C. Dick Geothermal Corp. v. Thermogenics, Inc., 890 F.2d 139, 146 (9th Cir. 1989) (en banc).
In a case — such as this one — that involves only a claim for injunctive relief under the Sherman Act, the factors regarding complex issues of damages or speculative or duplicative recoveries do not apply. See Bhan v. NME Hospitals, Inc., 772. F.2d 1467 (9th Cir. 1995); Bubar v. Ampco Foods, Inc., 752 F.2d 445, 449 n.2 (9th Cir. 1985); Reply, ECF No. 24 at 8 (acknowledging the point); FAC ¶¶ 139-159 (injunctive relief only).
Plaintiffs allege that they have been enrolled in a licensed health care plan that has a contractual relationship with Sutter for health care services." FAC ¶¶ 17-18. Sutter argues that they should plead more facts to establish their connection with Sutter and points to their failure to allege the following:
Motion at 15-16. Sutter's larger argument is that Plaintiffs are not parties to the contracts between Sutter and their health plans. They did not pay money to Sutter; their health plans did. Thus, any injury to them is indirect, and as "indirect purchasers," they lack standing under Illinois Brick co. v. Illinois, 431 U.S. 720 (1977)). Id. at 16-17.
The Ninth Circuit has parsed "antitrust injury" into four requirements: (1) unlawful conduct, (2) causing an injury to the plaintiff, (3) that flows from that which makes the conduct unlawful, and (4) that is of the type the antitrust laws were intended to prevent." American Ad Mgmt., Inc. 190 F.3d 1051, 1055 (9th Cir. 1999). Sutter's preliminary argument is really about requirements 2 through 4, and this section addresses only those requirements and discusses in the next section whether Plaintiffs sufficiently pleaded unlawful conduct (and concludes that they did not).
Assuming unlawful conduct in the form of tying and exclusive dealing that reduced competition from independent medical service providers and other medical provider networks, see FAC, ECF No. 11 at ¶¶ 54-56, 60, 80, 98-100, Plaintiffs allege that they were harmed because they are "enrolled in a licensed health care plan that has a contractual relationship with Sutter Health for health care services" and — as a result of the unlawful conduct — incurred inflated health care expenses in the form of higher premiums, co-payments, and out-of-pocket costs for other services. See id. ¶¶ 17, 18, 171. At the pleadings stage, the allegations are sufficient.
First, the court observes that Plaintiffs had more robust allegations in their opposition brief about their deductibles, co-pays, out-of-pocket expenses as direct purchasers of services that are consistent generally with their allegations already in the complaint. See Opposition, ECF No. 20 at 11 & n.3. In response to this proffer and the clarification that Plaintiffs seek only injunctive relief on the Sherman Act claims, Sutter points out that the allegations are not in the complaint,
In Forsyth v. Humana, Inc., 114 F.3d 1467, 1478 (9th Cir. 1997) (overruled on other grounds by Lacey v. Maricopa Co., 693 F.3d 896, 925 (9th Cir. 2012)), the Ninth Circuit found standing on summary judgment when the plaintiffs established that the practice of diverting indigent patients to other hospitals and threatening physicians who did not support its monopoly resulted in higher prices for hospital services that "translated into higher copayments and premium payments." Id. "Such an increase in consumer prices caused by the asserted conduct would constitute antitrust injury of the type the antitrust laws were designed to prevent." Id.
Sutter points out that the Forsyth plaintiffs received care from the defendant hospital and paid co-payments for those services. Reply, ECF No. 24 at 10. The court appreciates that receipt of services presents a different antitrust injury. See Blue Shield of Va. v. McCready, 457 U.S. 465, 468 (1982) (plaintiff was denied reimbursement for costs of psychotherapy services that she received). But the Forsyth court found antitrust injury based not only on increased copayments but also on increases in premium payments, see 14 F.3d at 925, and Plaintiffs here alleged that higher premiums (and increased costs) resulted from Sutter's allegedly anti-competitive conduct. See FAC ¶¶ 17 (refers to paying more for health care services), 18, 171.
Second, as to Sutter's argument that Plaintiffs are not parties to the contract and do not participate in the relevant market because they are not health plans or medical providers, certainly "the injured party [must] be a participant in the same market as the alleged malefactors." In re Dynamic Random Access Memory (DRAM) Antitrust Litig. ("DRAM II"), 536 F.Supp.2d 1129, 1137-38 (N.D. Cal. 2008) (collecting cases). But foreclosed physicians, patients, and health plans have challenged exclusive arrangements between hospitals and hospital-based physicians as unlawful tying arrangements or unlawful exclusive-dealing arrangements, and the standing analysis is not different merely because the challenged conduct is about exclusive arrangements with health plans and health-care service providers. Courts "routinely recognize the antitrust claims of market participants other than consumers or competitors." American Ad. Mgt., 190 F.3d at 1057; see also DRAM II, 536 F. Supp. 2d at 1140. Here, Plaintiffs allege that Sutter, through its allegedly anticompetitive conduct in the market for the health care services that they received through their health plans, caused them to pay higher prices for health care services,
Both Sherman Act claims are about unlawful tying or exclusive dealing arrangements. See FAC ¶¶ 143, 152-55. Sutter argues that Plaintiffs did not identify either. Motion, ECF No. 1 at 18-19.
Plaintiffs allege Sutter's "strategy" to establish monopoly power and acquire physician groups. FAC ¶¶ 50-59 (summarized on page 8). Plaintiffs's introduction refers to Sutter's (1) imposition of all-or-nothing "tying arrangements" that require health plans to use Sutter health providers or affiliated physicians or lose contracted access to any of them and (2) exclusive dealing arrangements between plans and Sutter providers or affiliated entitties. FAC ¶ 4. They also point to the following "tying" language that Sutter includes in its agreements with health plans: "Each payer accessing Sutter Health Providers shall designate ALL Sutter Health Providers . . . as participating providers unless a Payer excludes the entire Sutter Health provider network." Id. ¶ 60. They explain that the exclusive dealing arrangements require health plans to "actively encourage" patients who use a Sutter provider to use other Sutter providers. Id. ¶ 92; see supra pages 9-11 (excerpting allegations).
As Sutter points out, this is managed care.
Plaintiffs must provide some factual support for each essential element of the violations they allege. They did not do so.
Plaintiffs' Sherman Act claims require Plaintiffs to establish market power in a "relevant market," meaning a relevant product market and a relevant geographic market. See Omega Environmental, Inc. v. Gilbarco, Inc., 127 F.3d 1157, 1169 (9th Cir. 1997) (exclusive dealing); Illinois Tool Works Inc. v. Independent Ink, Inc., 547 U.S. 28, 42-43 (2006) (tying); Spectrum Sports, Inc. v. McQuillan, 506 U.S. 447, 456 (1993) (monopolization); Newcal Industries, Inc. v. Ikon Office Solutions, 513 F.3d 1038, 1044-45 & n.3 & n.4 (9th Cir. 2008) (standards the same under Sections 1 and 2). The relevant product market identifies the products or services that compete with each other, and the relevant geographic market identifies the area where the competition in the relevant product market takes place. See Los Angeles Mem'l Coliseum Comm'n v. NFL, 726 F.2d 1381, 1392 (9th Cir. 1974). A complaint may be dismissed under Rule 12(b)(6) if its "relevant market definition is facially unsustainable." Newcal Indus., 513 F.3d at 1044-45 & n.3.
Plaintiffs allege that the relevant market is "the provision of health care and related services" in 22 counties in Northern California. FAC ¶ 35. They define "health care and related services" as including but not limited to the following: inpatient hospital services; outpatient hospital services; physician services; services of other providers such as nurses, optometrists, psychologists, or nutritionists; diagnostic laboratory services; home health services; rehabilitation; physical or occupational therapy; preventive health services; emergency services; hospice services; chemical dependency services; and psychiatric services. Id. ¶ 36. Plaintiffs also allege, "[m]ost importantly for this action, there is a relevant market for the provision of contracted access to health care services through health care plans" (except for the closed-system Kaiser network) that must comply with the Knox-Keene Act. Id. ¶ 37.
As to the definition of the "product market," it is broad, and it is not apparent on the face of the complaint why it is a plausible market. This is not a case where all the services may be combined into a single relevant market. See Morgan, Strand, Wheeler & Biggs v. Radiology, 924 F.2d 1484, 1489-90 (9th Cir. 1991) (in determining relevant product market for, and who competed with, private radiologists, the court included office interpretations of radiology tests by nonradiologists and services provided by osteopathic radiologists and radiologists working at university hospitals); Weiss v. York Hosp., 745 F.2d 786, 826 (3d Cir. 1984) ("inpatient health care services" are a legitimate cluster market because a consumer of hospital services makes one purchase decision where to be hospitalized and subsequent treatment decisions are insulated from competitive effect). By contrast, the services here are not substitutes or related services "that enjoy reasonable interchangeability of use and cross-elasticity of demand." Oltz v. St. Peter's Cmty. Hosp., 861 F.2d 1440, 1446 (9th Cir. 1988); see also Tanaka v. Univ. of S. California, 252 F.3d 1059, 1063 (9th Cir. 2001). The only broad thing that Plaintiffs allege — without any factual support — is that it is one product market because it is all about contracted access to all health care services through health plans.
The geographic market similarly is defined broadly: 22 counties where Sutter provides services. The only support for that definition is the same argument that it is one market because it is about contracted access to services through health plans. If patients and their health plans are the purchasers, the relevant geographic market should be local, particularly given the interplay with the Knox-Keene Act's 15-minute/30-mile scope of service and accessibility requirements. Patients (or their physicians or health plans involved in the choice of where the medical services are provided) do not travel over large geographic areas for services. This suggests that the providers located outside the relatively small geographic area cannot foreclose a substantial percentage of the market from competition, see Allied Orthopedic Appliances, 592 F.2d at 996, or affect more than an insubstantial volume of commerce in the tied product market, see Cascade Health Solutions, 515 F.3d at 913.
Even assuming that some kind of 22-county regional geographic market could be established for managed care through health plans (which is all that Plaintiffs have alleged), Plaintiffs do not allege facts showing Sutter's market power either in the entire region or in particular counties.
In sum, Plaintiffs do not allege specific products (and instead allege products in the form of contracted access to health care services through health plans), and they do not allege any specific geographic areas (and instead allege an amorphous region of 22 counties that is not tethered to any factual allegations about Sutter's market power). The allegations about the relevant market do not identify the services that compete with each other or the geographic area where competition takes place. See Los Angeles Mem'l Coliseum Comm'n, 726 F.2d at 1392. The allegations thus are facially unsustainable. See Newcal Industries, Inc., 513 F.3d at 1044-45 & n.3.
Plaintiffs allege that Sutter violated California's Cartwright Act, which prohibits any combination "[t]o prevent competition in . . . the sale or purchase of merchandise . . . or any commodity. FAC, ¶¶ 160-168; Cal. Bus. & Prof. Code § 16720(c); Knevelbaard Dairies v. Kraft Foods, 232 F.3d 979, 986 (9th Cir. 2000). Plaintiffs' claim rests on the same allegations of tying and exclusive dealing arrangements. See, e.g., FAC ¶ 162. Sutter challenges Plaintiffs' antitrust standing and also argues that they fail to state a claim. Opposition, ECF No. 15 at 21-22. The court holds that Plaintiffs fail to state a claim.
Antitrust standing under the California Cartwright Act is broader than under the federal Sherman Act. See Knevelbaard Dairies, 232 F.3d at 987, 991. The parties disagree about whether the Associated General Contractors factors apply and — if they do — whether Plaintiffs have standing. Motion, ECF No. 15 at 29; Reply, ECF No. 24 at 8-12; Opposition, ECF No. 20 at 12-13. The California courts have not decided the issue (although intermediate appellate courts have applied the factors). See In Re Flash Memory Antitrust Litig., 643 F.Supp. 1133, 1151-52 (N.D. Cal. 2009); In re Graphics Processing Units Antitrust Litig., 540 F.Supp.2d 1085, 1097 (N.D. Cal. 2007) . The Ninth Circuit has not addressed the issue. Courts in this district have reached different conclusions. The court's view is that the cases that do not require the factors are persuasive. See In re Graphics Processing Units Antitrust Litig., 540 F. Supp. 2d at 1097 (N.D. Cal. 2007) ("some California appellate courts have used the AGC test.... [but t]his is not the same as showing that AGC has been adopted"; In re TFT-LCD (Flat Panel) Antitrust Litig., 586 F.Supp.2d 1109, 1120-24 (N.D. Cal. 2008) (need clear directive from state legislature or high court; plaintiffs had standing under factors anyway; In re Optical Disk Drive Antitrust Litig., No. 3:10-md-2143 RS, 2011 WL 3894376, at *11-12 (N.D. Cal. Aug. 3, 2011) (finding plaintiff had standing based on reasoning in In re TFT-LCD).
Because Plaintiffs fail to state a claim, the court does not decide the standing issue but likely would find standing. The analysis under the Sherman Act about nature of the injury is the same. The issue about Plaintiffs' status as indirect purchasers might be relevant to a Sherman Act damages claim under Illinois Brick, but they are not dispositive under the Cartwright Act because California courts have allowed indirect purchasers to pursue Cartwright Act claims that arise from agreements to restrain trade. See In Re Dynamic Random Access Memory (DRAM) Antitrust Litig., 516 F.Supp.2d 1072, 1087 (N.D. Cal. 2007); Opposition, ECF No. 15 at 29 n.7. The allegations about damages appear sufficient at the pleadings stage. The risk of duplicative recovery does not appear to be an issue in this kind of case where no direct purchasers are bringing claims, and it seems unlikely that they will.
Plaintiffs' claim rests on the same allegations about tying and exclusive dealing. Thus, Plaintiffs fail to state a Cartwright Act claim for the same reasons that they failed to state a section 1 Sherman Act claim.
Plaintiffs also charge that the tying and exclusive dealing is unfair competition in violation of California's Unfair Competition Law ("UCL"), which prohibits unlawful or unfair business practices. See FAC ¶ 172; Cal. Bus. & Prof. Code § 17200.
Plaintiffs claim for unjust enrichment is based on Sutter's retention of their overpayments and it is predicated on the same allegations about tying and exclusive dealing. See FAC ¶¶ 183-88. Sutter argues that unjust enrichment is not an independent cause of action under California law. Motion, ECF No. 15 at 30.
If a plaintiff invokes a valid theory of recovery, California courts allow claims for "unjust enrichment" to proceed, regardless of the label attached to the cause of action. See In re TFT-LCD (Flat Panel) Antitrust Litig., No. C 10-5616 SI, MDL No. 1827, 2012 WL 506327, at *4 (N.D. Cal. Feb. 15, 2012). "To state a claim for restitution, a plaintiff `must plead receipt of a benefit and the unjust retention of the benefit at the expense of another.'" Walters v. Fid. Mortg. of Cal., No. 2:09-cv-3317 FCD/KJM, 2010 WL 1493131, at *12 (E.D. Cal. Apr. 14, 2010) (quoting Lectrodryer v. SeoulBank, 77 Cal.App.4th 723, 726 (2000)). Courts in this district hold that California law permits restitution to be awarded for unjust enrichment "either (1) in lieu of breach of contract damages, where an asserted contract is found to be unenforceable or ineffective, or (2) where the defendant obtained a benefit from the plaintiff by fraud, duress, conversion, or similar conduct, but the plaintiff has chosen not to sue in tort." Oracle Corp. v. SAP AG, No. C 07-1658 PJH, 2008 WL 5234260, at *8 (N.D. Cal. Dec. 15, 2008)).
For the same reasons that Plaintiffs fail to state antitrust or UCL claims, they fail to state a claim for unjust enrichment. The court also would decline supplementary jurisdiction.
The court grants Sutter's motion to dismiss and denies as moot its request for judicial notice. Plaintiffs have 28 days from the date of this order to file a second amended complaint. This disposes of ECF Nos. 15 & 17.
